8 completed, 5 recruiting, 3 terminated, 1 unknown. 4 Phase 1, 3 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Recruiting 1 |
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow Hyperbilirubinemia, Hereditary: new trials by email Literature Review of Hyperbilirubinemia, Hereditary trials Research Report on Hyperbilirubinemia, Hereditary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome Imlifidase, GNT0003 - Crigler-Najjar Syndrome | Phase 2 | Recruiting | Genethon | 3 | 2024-11-08 | 2024-12-03 |
| Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) GT-UGT1A1-AAV8-02 - Crigler-Najjar Syndrome Type I | Phase 1 / Phase 2 | Recruiting | Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | 5 | 2024-11-06 | 2025-01-13 |
| Brown Adipose Tissue Activity in Gilbert's Syndrome analyzing brown adipose tissue, body composition and metabolic health - Gilbert Syndrome | Completed | Medical University of Vienna | 48 | 2024-03-06 | 2026-10-09 | |
| Baby Detect : Genomic Newborn Screening Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1 | Completed | Centre Hospitalier Universitaire de Liege | 6824 | 2022-09-01 | 2025-08-12 | |
| Biomarker for Gilbert Disease (BioGilbert) Meulengracht Syndrome, Hyperbilirubinemia | Withdrawn | CENTOGENE GmbH Rostock | 2018-08-20 | 2023-02-13 | ||
| HepaStem Long-Term Safety Registry Urea Cycle Disorder, Crigler-Najjar Syndrome | Terminated | Cellaion SA | 44 | 2018-04-04 | 2024-05-29 | |
| Gene Therapy for Severe Crigler Najjar Syndrome GNT0003 - Crigler-Najjar Syndrome | Not applicable | Recruiting | Genethon | 17 | 2018-03-19 | 2023-03-28 |
| Gene Transfer Clinical Study in Crigler-Najjar Syndrome AT342 - Crigler-Najjar Syndrome | Phase 1 | Terminated | Audentes Therapeutics | 1 | 2017-09-08 | 2022-05-18 |
| Clinical Assessment Study in Crigler-Najjar Syndrome Crigler-Najjar Syndrome | Completed | Audentes Therapeutics | 8 | 2017-03-10 | 2019-02-06 | |
| Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) Hepatitis Autoimmune Disease, Primary Biliary Cholangitis (PBC) | Recruiting | Asociación Española para el Estudio del Hígado | 5000 | 2016-01-01 | 2025-01-10 | |
| China Registry for Genetic / Metabolic Liver Diseases Standard of care - Genetic/Metabolic Liver Diseases | Recruiting | Beijing Friendship Hospital | 20000 | 2015-06-13 | 2017-04-27 | |
| New Phototherapy Device to Treat Patients With Crigler-Najjar Disease Arm1 homemade phototherapy treatment, DRAP - Crigler Najjar Syndrome, Children | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 6 | 2014-12-01 | 2017-09-12 |
| Immunity Against AAV in Crigler Najjar Patient Blood sample for immunology - Crigler Najjar Syndrome | Completed | Genethon | 49 | 2014-11-01 | 2017-12-13 | |
| Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001) Urea Cycle Disorders, Crigler Najjar Syndrome | Completed | Cellaion SA | 9 | 2013-03-01 | 2019-05-28 | |
| Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) HepaStem - Urea Cycle Disorders, Crigler Najjar Syndrome | Phase 1 / Phase 2 | Completed | Cellaion SA | 20 | 2012-03-01 | 2020-10-19 |
| Hepatocyte Transplantation for Liver Based Metabolic Disorders human hepatocyte transplantation, Preparative Radiation Therapy - Metabolic Diseases | Phase 1 | Terminated | Ira Fox | 5 | 2011-03-01 | 2022-12-07 |
| Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia Gene mutation sample - Hyperbilirubinemia, Jaundice | Completed | Pediatrix | 450 | 2006-09-01 | 2008-01-28 | |
| Orlistat Treatment of Crigler-Najjar Disease orlistat - Crigler-Najjar Syndrome | Not applicable | Completed | University Medical Center Groningen | 16 | 2003-09-01 | 2007-04-18 |
Crigler-Najjar Syndrome (13) · Urea Cycle Disorders, Inborn (4) · Gilbert Disease (3) · Carbamoyl-Phosphate Synthase I Deficiency Disease (2) · Citrullinemia (2) · Glucosephosphate Dehydrogenase Deficiency (2) · Hepatolenticular Degeneration (2) · Hyperbilirubinemia (2) · Ornithine Carbamoyltransferase Deficiency Disease (2) · 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1) · 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1) · Acidemia, isovaleric (1) · Acute-On-Chronic Liver Failure (1) · Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18) · Metabolism, Inborn Errors (18) · Nutritional and Metabolic Diseases (18) · Genetic Diseases, Inborn (17) · Metabolic Diseases (17) · Brain Diseases (6) · Brain Diseases, Metabolic (6) · Brain Diseases, Metabolic, Inborn (6) · Central Nervous System Diseases (6) · Nervous System Diseases (6) · Amino Acid Metabolism, Inborn Errors (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Digestive System Diseases (4)
Blood Specimen Collection (1) · Body Composition (1) · Mac-1-like protein, Streptococcus (1) · Orlistat (1) · Standard of Care (1)
Cellaion SA (3) · Genethon (3) · Audentes Therapeutics (2) · Asociación Española para el Estudio del Hígado (1) · Assistance Publique - Hôpitaux de Paris (1) · Beijing Friendship Hospital (1) · CENTOGENE GmbH Rostock (1) · Centre Hospitalier Universitaire de Liege (1) · Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare (1) · Ira Fox (1) · Medical University of Vienna (1) · Pediatrix (1) · University Medical Center Groningen (1)
France (6) · Belgium (4) · United States (4) · Israel (3) · United Kingdom (3) · Italy (2) · Netherlands (2) · Spain (2) · Austria (1) · Bulgaria (1) · China (1) · Egypt (1) · India (1) · Poland (1) · Russia (1)
Anja M. Hafkamp, MD (1) · Dries Dobbelaere, MD/Prof (1) · Giuliano Torre, MD (1) · Hanna Mandel, MD (1) · Henkjan J. Verkade, MD, PhD (1) · Ira J Fox, MD (1) · Jidong Jia, Doctor (1) · Jon Watchko, MD (1) · Karl-Heinz Wagner, Univ.-Prof. Mag. (1) · Laurent Servais (1) · Maarten Sinaasappel, MD (1)
PMID 19858149, PMID 22789058, PMID 32028991, PMID 35668470, PMID 37585628